SymlinPen 1000 ug/mL
pramlintide acetate · INJECTION · AstraZeneca Pharmaceuticals LP
SymlinPen is a injection containing pramlintide acetate at 1000 ug/mL, taken subcutaneous. Manufactured by AstraZeneca Pharmaceuticals LP.
Key Facts
- Brand Name
- SymlinPen
- Generic Name
- pramlintide acetate
- NDC Code (Product)
0310-6627- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 1000 ug/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA021332
- Marketing Start
- 01/08/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is SymlinPen used for?
SymlinPen contains pramlintide acetate. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is SymlinPen a controlled substance?
SymlinPen is not classified as a controlled substance by the DEA.
What is the generic name for SymlinPen?
The generic name for SymlinPen is pramlintide acetate. There are no other listed brand versions of pramlintide acetate.
What is the NDC code for SymlinPen 1000 ug/mL?
The NDC (National Drug Code) for SymlinPen 1000 ug/mL is 0310-6627, listed by AstraZeneca Pharmaceuticals LP.
Other SymlinPen Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)